GCM
WST icon

Graham Capital Management’s West Pharmaceutical WST Stock Holding History

Graham Capital Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5,347
Closed -$1.47M – 1548
2025
Q4 		$1.47M Buy
5,347
+1,544
+41% +$422K 0.04% 299
2025
Q3 		$998K Buy
+3,803
New +$924K 0.02% 385
2023
Q3 		– Sell
-886
Closed -$339K – 1317
2023
Q2 		$339K Buy
+886
New +$317K 0.01% 645
2022
Q2 		– Sell
-521
Closed -$213K – 1270
2022
Q1 		$213K Buy
+521
New +$204K 0.01% 819

Other funds holding WST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Graham Capital Management's WST Position: Q1 2026 in Review

Graham Capital Management sold out of West Pharmaceutical (WST) in Q1 2026, closing a stake of 5,347 shares — an estimated $1.47M sold.

Graham Capital Management first reported a position in WST in Q1 2022 and held it in 4 quarters. The position peaked at $1.47M in Q4 2025. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • Graham Capital Management reported no remaining West Pharmaceutical position as of Q1 2026 after selling out during the quarter.
  • Graham Capital Management sold 5,347 West Pharmaceutical shares in Q1 2026, an estimated $1.47M.
  • Graham Capital Management first reported a position in West Pharmaceutical in Q1 2022 and held it in 4 quarters.
  • Graham Capital Management's West Pharmaceutical position peaked at $1.47M in Q4 2025.
  • 753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Graham Capital Management's 13F filing for Q1 2026, filed 15 May 2026.